(Q43854920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

F Cozzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P Marson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Rosada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

G De Silvestro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Bullo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

S Todesco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

25-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

Scleroderma--clinical aspects

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Treatment of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Outcome measurement in scleroderma clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Therapeutic apheresis in autoimmune and rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Scleroderma: immunopathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Plasmapheresis and immunosuppressive drug therapy in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

[Treatment of generalized scleroderma by plasma exchange. Apropos of 3 cases]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Treatment of progressive systemic sclerosis with plasma exchange. Seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Treatment of progressive systemic sclerosis by plasma exchange: long-term results in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Expression and Function of Surface Antigens on Scleroderma Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Collagen synthesis by scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Soluble and cellular markers of immune activation in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

The use of serologic markers for collagen synthesis and degradation in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2801%2900078-7

7 January 2021

10.1016/S1473-0502(01)00078-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11791759%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference